NVCR 8-K 2026-06-30

NovoCure Ltd (NVCR) 8-K dated 2026-06-30 — accession 0001645113-26-000056. This URL is the filing, not the NVCR hub.

NovoCure Ltd (NVCR) is a medical devices company listed on US.

NovoCure Ltd filed a 8-K on 2026-06-30. Accession 0001645113-26-000056.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. NVCR currently screens at market cap $1.99B.

Not investment advice. The NVCR SEC hub lists recent forms. The stock page is the research view.